INTERMOLECULAR INC. overview

Intermolecular Reports Second Quarter 2019 Financial Results PR Newswire SAN JOSE, Calif., Aug. 8, 2019 SAN JOSE, Calif. , Aug. 8, 2019 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for its second quarter ended June 30, 2019 . Second Quarter of 2019 Financial Results Revenue for the second quarter of 2019 was $4.6 million , a decrease of 31% from $6.7 million in the first quarter of 2019, and a decrease of 53%...

Intermolecular to Lead Session on 3D XPoint: Current Implementations and Future Trends at Flash Memory Summit 2019 PR Newswire SAN JOSE, Calif., Aug. 1, 2019 SAN JOSE, Calif. , Aug. 1, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, today announced Intermolecular Senior Vice President of Programs and Operations Milind Weling , will be leading a special session, 3D XPoint: Current Implementations and Future Trends within the New...

Intermolecular Stockholders Approve Merck KGaA, Darmstadt, Germany's Proposed Acquisition of Intermolecular PR Newswire SAN JOSE, Calif., July 17, 2019 SAN JOSE, Calif. , July 17, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI) announced today that the stockholders of Intermolecular have approved the previously announced proposed acquisition of all outstanding shares of common stock of Intermolecular by Merck KGaA, Darmstadt, Germany , through its subsidiary EMD Group Holding II, Inc. At...

WeissLaw LLP Investigates Intermolecular, Inc. Acquisition PR Newswire NEW YORK, May 15, 2019 NEW YORK , May 15, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Intermolecular, Inc. ("Intermolecular" or the "Company") (NASDAQ: IMI) in connection with the proposed acquisition of the Company by a wholly owned subsidiary of Merck KGaA. Under the terms of the acquisition agreement valued at $62 million ,...

Intermolecular Reports First Quarter 2019 Financial Results PR Newswire SAN JOSE, Calif., May 14, 2019 SAN JOSE, Calif. , May 14, 2019 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for its first quarter ended March 31, 2019 . Q1 2019 Financial and Operational Highlights Program revenue totaled $6.4 million or 96% of total revenue of $6.7 million . Gross profit totaled $4.8 million or 73% of total revenue....

Intermolecular to be acquired by Merck KGaA, Darmstadt, Germany for $1.20 per share in an all cash transaction - Acquisition to strengthen technology offering and diversify performance materials portfolio of Merck KGaA, Darmstadt, Germany - Transaction expected to close in the second half of 2019 PR Newswire SAN JOSE, Calif., May 6, 2019 SAN JOSE, Calif. , May 6, 2019 /PRNewswire/ --Intermolecular, Inc. (NASDAQ: IMI) has signed a definitive agreement pursuant to which a wholly owned subsidiary...

Intermolecular Sets Fiscal First Quarter 2019 Earnings Call for Tuesday, May 14, 2019 at 5 p.m. ET PR Newswire SAN JOSE, Calif., April 24, 2019 SAN JOSE, Calif. , April 24, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, will hold a conference call on Tuesday, May 14, 2019 at 5:00 p.m. Eastern time ( 2:00 p.m. Pacific time ) to discuss its financial results for the fiscal first quarter ended March 31, 2019 . Financial results will...

Intermolecular Reports Fourth Quarter and Full Year 2018 Financial Results 2018 Marked First Full Year of Positive Adjusted EBITDA Since 2013 Positive Operating Cash Flow of $5.9 million in 2018 PR Newswire SAN JOSE, Calif., Feb. 12, 2019 SAN JOSE, Calif. , Feb. 12, 2019 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for the fourth quarter and full year ended December 31, 2018 . Q4 2018 Financial and Operational...